Incentive Compensation Planning

MOTIVATE. RETAIN. IMPROVE PERFORMANCE.

With the right IC Plan, you can attract and retain key employees, identify with shareholders, and align interests of employees and the company while achieving sales targets.

Yet, the complexities of creating and managing the “right” IC plan can be staggering. This is where KMK’s expertise can be invaluable. We will work with you to build a customized IC plan based on your product(s) features and life cycle, using the appropriate Goal-based, Commission-based, Rank, or Management by Objective (MBO) design.

KMK can further improve performance with our proprietary “Reward For Growth” IC model, which reduces plan bias by testing the fairness of the proposed IC plan. Then, by analyzing the data associated with sales, we can provide insights that help your reps make better decisions in real-time. You gain more trust from your reps. They achieve better performance.

Related insights

Vakhtang Agayan Named New CTO at KMK Consulting Inc.

The Art of Building a Flexible Sales Force During COVID-19

Localizing Your BioPharma Commercial Strategy

Design Thinking Applied: Design Thinking in Communications Development Health Care Design Thinking Day

Design Thinking Applied: The Cognitive Interview Health Care Design Thinking Day

Eliciting Mental Models Health Care Design Thinking Day

Design Thinking and the Decision Journey Health Care Design Thinking Day

Developing Empathy to Deepen Understanding Health Care Design Thinking Day

Design Thinking Panel Discussion Health Care Design Thinking Day

What is Design Thinking?

Keynote Speaker Health Care Design Thinking Day

Health Care Design Thinking Day

KMK Consulting, Inc. Launches On-Demand SME Network

KMK Donates to COVID Relief Effort in India

KMK MAKES DONATION TO AAPI COMMUNITY FUND CHARITY OF GREATER NEW YORK

Making Remote Work in India with Pratik Panchal

COVID Success Stories in India – KMK Consulting Inc.

KMK Consulting, Inc. Earns 2021 Great Place to Work Certification™

Migraine Study Demonstrates Impact of Treatment Failures on Healthcare System

The Ultimate Plan for Strong Analytics Support to Drive Business Decisions : A no-compromise solution on quality and value

A Roadmap to Success: Five Guiding Principles to Incentive Compensation Planning

Pharma Companies’ Sales Reporting Efforts Often Fall Short. A look at why this occurs and how to avoid it in the future.

KMK Value Based Medicine

Unlock forward looking Insights via Machine Learning

GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma

Genentech, Pfizer and Merck Identified as the Top Three Companies Driving Therapeutic Innovation in Breast Cancer

It is time to use an Interactive Flow Diagram to Tell Patient Narratives

How to become the Iron Man of Data Analytics?

Exploring the significance of Real World Evidence and Real World Data

HEOR Principal Huanxue Zhou’s Manuscript in BURNS Journal

Smarter Real World Evidence: A Flexible Client-Centered Dashboard Can Help Data Tell a Better Story

HEOR Principal Huanxue Zhou’s Manuscript in International Journal of MS Care

Gritty and Fearless: How to succeed at KMK

East Meets West: The KMK Way

Learning the Ropes: An Intern’s Story at KMK

Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS

Readjusting Your Field Force in the World of COVID-19

How to Reach Oncologists when Face-to-Face Interaction is Impossible

High Cost of Medication Tops the List of Challenges for Gastroenterologists Treating IBS

What are the most important asthma products and what makes them superior?

What Innovations are Oncologists Looking Forward to in Breast Cancer Therapy?

KMK’s Split Credit Tool Improves IC Performance

KMK’s Employee Performance Tool Streamlines HQ/Sales Rep Calibration

Field Force Re-Optimization in Anticipation of Loss of Exclusivity (LOE)

IC Plan Design in Defense of Competitive Entry

Sales Force Effectiveness for Top 20 Pharma

Real World Evidence to Support Payer Negotiation

Leverage Anonymized Patient Level Data (APLD) to Identify Market Opportunities